A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

The problem with pancreatic cancer is that we often catch it too late,” he stated. The PAC-MANN test aims to enable ...

OHSU's PAC-MANN test offers a breakthrough in pancreatic cancer detection, using a small blood sample to monitor protease ...

The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 ...

Ipsen expects total sales growth of more than 5% at constant exchange rates in 2025, supported by the continued expansion of products like IQIRVO, ONIVYDE, and Bylvay. However, Somatuline faces ...

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...

Oncotelic Therapeutics, Inc (OTCQB:OTLC). Oncotelic Therapeutics, a leader in RNA-based therapeutics, is pleased to announce that Vuong Trieu, Ph.D., Chairman & CEO, will be delivering a featured ...

诱导 PDAC 细胞铁死亡可降低由 ACOT8 高表达引起的吉西他滨耐药性 ：研究人员将吉西他滨与铁死亡诱导剂 erastin 联合处理细胞， 实验显示联合处理显著降低了细胞对吉西他滨的耐药性，ACOT8 表达的细胞和类器官模型的生长也受到明显抑制。这表明 ACOT8 的抗铁死亡作用是导致吉西他滨耐药的关键因素。

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...